Study Group: Zocor Pricing Experts (US)(?)
Council Members in this Study Group: 40
Request a survey with this Study Group
Leading Experts in this Study Group
Dea Belazi, PharmD, MPH, PAHM
Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
Dea Belazi, PharmD, MPH, PAHM, is currently a consultant working with health plans and pharmaceutical companies. He was previously the Senior Director of Pharmacy Services for Independence Blue Cross, a large commercial and Medicare health plan in Pennsylvania. Prior to this position, he was the Associate...
President
Pharmacy Express Services, Inc.
Bruce Goldberg is the Founder and President of Pharmacy Express Services, Inc., a retail chain based in Nebraska. Mr. Goldberg is a pharmacist and has experience in managed care with PBM contracting and general pharmacy network management. He has developed a program which will allow generic and therapeutic...
Joe Renner, MBACEO and part owner
Zydus Pharmaceuticals USA Inc
Joseph D. Renner, MBA, is CEO of Zydus Pharmaceuticals (USA) Inc., the US affiliate of Zydus Cadila, an Indian generic pharmaceutical manufacturer. Prior to this, Mr. Renner was the EVP/COO of Geneva Pharmaceuticals, a generics manufacturer and division of Novartis. In addition, Mr. Renner spent 17...
David WrightPresident
Wright Consulting Group
David Wright is the President at Wright Consulting Group, California, a company providing consulting services to the healthcare sector. He provides marketing support for retail pharmacy chains and independents. Mr. Wright negotiates contracts for purchasing branded and generic pharmaceuticals and puts...
Tim Gallagher, RPhExecutive Vice President of Pharmacy Operations
Astrup Drug, Inc.
Tim Gallagher, RPh, is the Executive Vice President of Pharmacy Operations at Astrup Drug, Inc. Minnesota. He manages all aspects of pharmacy operations for the company. Mr. Gallagher has been a practicing pharmacist for 23 years in both the chain and independent community pharmacy setting. He has also...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families. My grandpa used to call this stuff...
It is important to understand that geographic placement of these clinics is important. I think these clinics will continue to pop up until the industry feels out exactly where the market is. We are located in the southwest suburbs of Chicago, and there are many of these clinics which are...
Increased FDA warnings on ESAs, suchas Epogen, Procrit and Aranesp will provide payers the ability to further restrict these agents. Restrictions will come in the form of prior authorizations and other utilization management techniques.
An FDA advisory panel recently voted to stop the recommendation of otc cough and cold products in children less than 12 years of age. For decades parents have administered otc cough and could products to infants and young children. Even the FDA Advisory Committee had dissention amongst their members,...
Pfizers failure on Exubera were not of safety issues, or complicated device, or even consumer marketing problems. Their biggest issue that brought failure was the lack of payer coverage. Almost no payer in the US added Exubera to their formulary or saw any value over injectable insulin...
GLG InstituteSM Seminars with this Study Group's Leading Experts(?)
Recent Seminars
Most Common Company Types:
- Pharmacy or Drug Store, Chain
- Pharmacy or Drug Store, Independent/Local
- Managed Care Health Insurer, For-Profit
- Managed Care Health Insurer, Non-Profit
- Consultancy, Pharma-Focused
- Healthcare Management
- Blue Cross/Blue Shield Non-Profit Health Insurer
- Pharmaceuticals Manufacturer
Most Common Job Types:
- Pharmacist - RPh/PharmD
- Owner
- President
- Director
- Chief Executive Officer
- Manager
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms